AUR-201

· Auregen Biotherapeutics, SA

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for AUR-201, covering 2025-11-19 to 2025-11-21. Get the full timeline:

Most recent: Clinical Trial Update: Subcutaneous Implant Combination Product (AUR-201) in Patients With Unilateral Microtia [Phase 1, Phase 2]